Benzinga's Top Pre-Market NASDAQ Losers (SNTS, CSKI, CHBT, QGEN)

Santarus Inc SNTS dipped 13.64% to $2.85 in the pre-market session. SNTS reported wider-than-expected Q3 loss. China Sky One Medical Inc CSKI lost 12.23% to $8.68 in the pre-market session. CSKI posted a 16.3% y/y decline in its Q3 total revenue. China-Biotics Inc CHBT fell 9.42% to $12.50 in the pre-market session. CHBT reported a 37.6% y/y rise in its FQ2 revenue. Qiagen NV QGEN slipped 6.05% to $17.70 in the pre-market trading. QGEN posted a year-over-year decline in its Q3 profit and lowered its revenue projections for the year. Read more from Benzinga's Markets.